Similar articles

• Cellular reactions against Burkitt lymphoma cells. II. Effector cells obtained by allogeneic stimulation in mixed leukocyte cultures.

  Golub SH, Hewetson JF, Svedmyr EA, Singh S. Golub SH, et al. Int J Cancer. 1972 Jul 15;10(1):150-6. doi: 10.1002/ijc.2910100120. Int J Cancer. 1972. PMID: 4122453 No abstract available.
• Cellular reactions against Burkitt lymphoma cells. 3. Effector cell activity of leukocytes stimulated in vitro with autochthonous cultured lymphoma cells.

  Golub SH, Svedmyr EA, Hewetson JF, Klein G, Singh S. Golub SH, et al. Int J Cancer. 1972 Jul 15;10(1):157-64. doi: 10.1002/ijc.2910100121. Int J Cancer. 1972. PMID: 4122454 No abstract available.
• Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients.

  Gunvén P, Klein G, Henle G, Henle W, Clifford P. Gunvén P, et al. Nature. 1970 Dec 12;228(5276):1053-6. doi: 10.1038/2281053a0. Nature. 1970. PMID: 4320656 No abstract available.
• Immunological aspects of Burkitt's lymphoma.

  Klein G. Klein G. Adv Immunol. 1971;14:187-250. doi: 10.1016/s0065-2776(08)60285-0. Adv Immunol. 1971. PMID: 4332352 Review. No abstract available.
• Virus-induced antigens - a review.

  Klein G. Klein G. IARC Sci Publ (1971). 1975;(11 Pt 1):293-308. IARC Sci Publ (1971). 1975. PMID: 190131 Review. No abstract available.